Literature DB >> 16474040

No evidence of parvovirus B19 in tissue samples from patients with polyarteritis nodosa and microscopic polyangiitis as assessed by the polymerase chain reaction.

Z Sachetto, S C B Costa, P D Andrade, R A Conde, E M I Amstalden, A M Samara, S R M Fernandes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16474040      PMCID： PMC1798056          DOI： 10.1136/ard.2005.040113

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin.

Authors:  M Viguier; L Guillevin; L Laroche
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

2.  Polyarteritis nodosa and parvovirus B19 infection.

Authors:  L C Corman; D J Dolson
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction.

Authors:  R Alvarez-Lafuente; B Fernández-Gutiérrez; J A Jover; E Júdez; E Loza; D Clemente; J A García-Asenjo; J R Lamas
Journal:  Ann Rheum Dis       Date:  2005-05       Impact factor: 19.103

5.  Polyarteritis nodosa and parvovirus B19.

Authors:  M Leruez-Ville; A Laugé; F Morinet; L Guillevin; P Dény
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

Review 6.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

7.  Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis.

Authors:  S Tanawattanacharoen; R J Falk; J C Jennette; J B Kopp
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

8.  Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.

Authors:  J Hermann; U Demel; D Stünzner; E Daghofer; G Tilz; W Graninger
Journal:  Ann Rheum Dis       Date:  2004-10-14       Impact factor: 19.103

9.  Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

Authors:  T H Finkel; T J Török; P J Ferguson; E L Durigon; S R Zaki; D Y Leung; R J Harbeck; E W Gelfand; F T Saulsbury; J R Hollister
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

10.  [Periarteritis nodosa and parvovirus B19 infection].

Authors:  F Gaches; V Loustaud; E Vidal; L Delaire; J B Guiard-Schmid; E Lavoine; P Negrier; F Liozon
Journal:  Rev Med Interne       Date:  1993-05       Impact factor: 0.728
  10 in total
  2 in total

1.  Molecular evidence of parvovirus B19 in the cutaneous polyarteritis nodosa tissue from a patient with parvovirus-associated hemophagocytic syndrome: Case report.

Authors:  Ji Yun Jeong; Ji Young Park; Ji Yeon Ham; Ki Tae Kwon; Seungwoo Han
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

Review 2.  [Virus and systemic vasculitis].

Authors:  B Cervantes Bonet; J L Callejas Rubio; N Ortego Centeno
Journal:  Rev Clin Esp       Date:  2006-11       Impact factor: 1.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.